Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
4,814
-43
-0.9% -$9.25K 0.69% 24
2026
Q1
$1.04M Sell
4,857
-293
-6% -$65K 0.67% 21
2025
Q4
$1.18M Buy
5,150
+241
+5% +$54.9K 0.7% 18
2025
Q3
$1.14M Buy
4,909
+184
+4% +$37.5K 0.73% 20
2025
Q2
$877K Sell
4,725
-49
-1% -$9.11K 0.63% 23
2025
Q1
$1M Buy
4,774
+7
+0.1% +$1.36K 1.02% 22
2024
Q4
$847K Buy
4,767
+130
+3% +$23.9K 0.81% 24
2024
Q3
$916K Buy
4,637
+18
+0.4% +$3.36K 0.93% 22
2024
Q2
$792K Buy
4,619
+41
+0.9% +$6.79K 0.86% 22
2024
Q1
$828K Sell
4,578
-90
-2% -$15.5K 0.99% 22
2023
Q4
$723K Buy
+4,668
New +$681K 0.94% 22

Other funds holding ABBV

OneFund LLC's ABBV Position: Q2 2026 in Review

OneFund LLC reduced its AbbVie (ABBV) stake by 0.89% in Q2 2026, selling an estimated $9.25K and leaving 4,814 shares worth $1.21M. The position accounts for 0.69% of the portfolio, ranked #24.

OneFund LLC first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • OneFund LLC held 4,814 shares of AbbVie worth $1.21M as of Q2 2026.
  • OneFund LLC sold 43 AbbVie shares in Q2 2026, an estimated $9.25K.
  • AbbVie made up 0.69% of OneFund LLC's portfolio in Q2 2026, its #24 holding.
  • OneFund LLC first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.